ECRAID-Base

Building upon the foundations laid down by COMBACTE and PREPARE, the EU-funded project ECRAID-Base advances clinical research in the field of infectious disease in Europe.

Updates

Study Tags (field_study_tags)

29.11.2024

Module 6 of Adaptive Trial Designs series: Ethical, administrative, regulatory, logistical considerations

The final part of our year-long training series is now available.

21.10.2024

Tracking candidemia trends and antifungal resistance patterns across Europe: An in-depth analysis of surveillance systems and surveillance studies

Background: The WHO fungal priority list classifies Candida species as critical and high-priority pathogens, and the WHO GLASS f…

21.10.2024

EPI-Net paper on bloodstream infections by fungi of the Candida genus

The comprehensive review of the latest data on candidemia and antifungal resistance rates for six pathogens.

16.10.2024

Grant management: The solid base that supports ECRAID-Base

30.09.2024

Watch Module 5 of Adaptive Trial Designs series: platform trials

Plus the PRACTical design and the RECOVERY, REMAP-CAP, and NeoSep1 trials.

31.07.2024

Module 4 of Adaptive Clinical Trial Designs series is now live

It introduces two adaptive randomisation designs and three case studies, including REMAP-CAP.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No. 965313.